Kurt Rasmussen - Publications

Affiliations: 
Eli Lilly, Indianapolis, IN, United States 

94 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Zhang H, Reynolds J, Rasmussen KJR, Ellingwood BR. Reliability-Based Load Requirements for Formwork Shores during Concrete Placement Journal of Structural Engineering (United States). 142. DOI: 10.1061/(ASCE)ST.1943-541X.0001362  0.44
2016 Tao Z, Rasmussen KJR. Stress-strain model for ferritic stainless steels Journal of Materials in Civil Engineering. 28. DOI: 10.1061/(ASCE)MT.1943-5533.0001393  0.44
2016 Wang R, Han LH, Zhao XL, Rasmussen KJR. Analytical behavior of concrete filled double steel tubular (CFDST) members under lateral impact Thin-Walled Structures. 101: 129-140. DOI: 10.1016/j.tws.2015.12.006  0.44
2016 Rasmussen KJR, Zhang X, Zhang H. Beam-element-based analysis of locally and/or distortionally buckled members: Theory Thin-Walled Structures. 98: 285-292. DOI: 10.1016/j.tws.2015.06.020  0.44
2016 Zhang X, Rasmussen KJR, Zhang H. Second-order effects in locally and/or distortionally buckled frames and design based on beam element analysis Journal of Constructional Steel Research. 122: 57-69. DOI: 10.1016/j.jcsr.2016.01.022  0.44
2015 Niu S, Rasmussen KJR, Fan F. Local-Global Interaction Buckling of Stainless Steel I-Beams. I: Experimental Investigation Journal of Structural Engineering (United States). 141. DOI: 10.1061/(ASCE)ST.1943-541X.0001137  0.44
2015 Niu S, Rasmussen KJR, Fan F. Local-Global Interaction Buckling of Stainless Steel I-Beams. II: Numerical Study and Design Journal of Structural Engineering (United States). 141. DOI: 10.1061/(ASCE)ST.1943-541X.0001131  0.44
2015 Wang R, Han LH, Zhao XL, Rasmussen KJR. Experimental behavior of concrete filled double steel tubular (CFDST) members under low velocity drop weight impact Thin-Walled Structures. 97: 279-295. DOI: 10.1016/j.tws.2015.09.009  0.44
2015 Trouncer AN, Rasmussen KJR. A rational procedure for modelling imperfections in advanced analysis of frames with locally unstable members Thin-Walled Structures. 96: 183-201. DOI: 10.1016/j.tws.2015.08.010  0.44
2015 Zhang X, Rasmussen KJR, Zhang H. Beam-element-based analysis of locally and/or distortionally buckled members: Application Thin-Walled Structures. 95: 127-137. DOI: 10.1016/j.tws.2015.06.021  0.44
2015 Dai H, Zhang H, Rasmussen KJR, Wang W. Wavelet density-based adaptive importance sampling method Structural Safety. 52: 161-169. DOI: 10.1016/j.strusafe.2014.02.003  0.44
2015 Zhang X, Rasmussen KJR, Zhang H. Structural modeling of cold-formed steel portal frames Structures. 4: 58-68. DOI: 10.1016/j.istruc.2015.10.010  0.44
2014 Sena Cardoso F, Rasmussen KJR. Behavior and design of concentrically loaded T-section steel columns Journal of Structural Engineering (United States). 140. DOI: 10.1061/(ASCE)ST.1943-541X.0000969  0.44
2014 Gilbert BP, Teh LH, Badet RX, Rasmussen KJR. Influence of pallets on the behaviour and design of steel drive-in racks Journal of Constructional Steel Research. 97: 10-23. DOI: 10.1016/j.jcsr.2014.01.013  0.44
2014 Zhang H, Ellingwood BR, Rasmussen KJR. System reliabilities in steel structural frame design by inelastic analysis Engineering Structures. 81: 341-348. DOI: 10.1016/j.engstruct.2014.10.003  0.44
2012 Fell MJ, Katner JS, Rasmussen K, Nikolayev A, Kuo MS, Nelson DL, Perry KW, Svensson KA. Typical and atypical antipsychotic drugs increase extracellular histamine levels in the rat medial prefrontal cortex: contribution of histamine h(1) receptor blockade. Frontiers in Psychiatry. 3: 49. PMID 22629251 DOI: 10.3389/fpsyt.2012.00049  1
2011 Fell MJ, Witkin JM, Falcone JF, Katner JS, Perry KW, Hart J, Rorick-Kehn L, Overshiner CD, Rasmussen K, Chaney SF, Benvenga MJ, Li X, Marlow DL, Thompson LK, Luecke SK, et al. N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes. The Journal of Pharmacology and Experimental Therapeutics. 336: 165-77. PMID 20947638 DOI: 10.1124/jpet.110.172957  1
2009 Gehlert DR, Rasmussen K, Shaw J, Li X, Ardayfio P, Craft L, Coskun T, Zhang HY, Chen Y, Witkin JM. Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression. The Journal of Pharmacology and Experimental Therapeutics. 329: 429-38. PMID 19182070 DOI: 10.1124/jpet.108.143362  1
2007 Rasmussen K, Hsu MA, Noone S, Johnson BG, Thompson LK, Hemrick-Luecke SK. The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the treatment of extrapyramidal symptoms. Schizophrenia Bulletin. 33: 1291-7. PMID 17660489 DOI: 10.1093/schbul/sbm087  1
2007 Rasmussen K, Hsu MA, Yang Y. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 786-92. PMID 17063151 DOI: 10.1038/sj.npp.1301239  1
2006 Verma V, Rasmussen K, Dawe GS. Effects of short-term and chronic olanzapine treatment on immediate early gene protein and tyrosine hydroxylase immunoreactivity in the rat locus coeruleus and medial prefrontal cortex. Neuroscience. 143: 573-85. PMID 16979829 DOI: 10.1016/j.neuroscience.2006.08.010  1
2006 Rasmussen K. Creating more effective antidepressants: clues from the clinic. Drug Discovery Today. 11: 623-31. PMID 16793531 DOI: 10.1016/j.drudis.2006.05.004  1
2006 Takeuchi K, Kohn TJ, Honigschmidt NA, Rocco VP, Spinazze PG, Hemrick-Luecke SK, Thompson LK, Evans DC, Rasmussen K, Koger D, Lodge D, Martin LJ, Shaw J, Threlkeld PG, Wong DT. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5. Bioorganic & Medicinal Chemistry Letters. 16: 2347-51. PMID 16298130 DOI: 10.1016/j.bmcl.2005.11.007  1
2005 Rasmussen K, Benvenga MJ, Bymaster FP, Calligaro DO, Cohen IR, Falcone JF, Hemrick-Luecke SK, Martin FM, Moore NA, Nisenbaum LK, Schaus JM, Sundquist SJ, Tupper DE, Wiernicki TR, Nelson DL. Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine. The Journal of Pharmacology and Experimental Therapeutics. 315: 1265-77. PMID 16141369 DOI: 10.1124/jpet.105.089326  1
2005 Seager MA, Barth VN, Phebus LA, Rasmussen K. Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: implications for bipolar disorder. Psychopharmacology. 181: 126-33. PMID 15719213 DOI: 10.1007/s00213-005-2198-2  1
2005 Rasmussen K, Martin H, Berger JE, Seager MA. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats. Neuropharmacology. 48: 173-80. PMID 15695156 DOI: 10.1016/j.neuropharm.2004.09.010  1
2004 Seager MA, Huff KD, Barth VN, Phebus LA, Rasmussen K. Fluoxetine administration potentiates the effect of olanzapine on locus coeruleus neuronal activity. Biological Psychiatry. 55: 1103-9. PMID 15158430 DOI: 10.1016/j.biopsych.2004.02.012  1
2004 Rasmussen K, Hsu MA, Vandergriff J. The selective mGlu2/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons. Neuropharmacology. 46: 620-8. PMID 14996539 DOI: 10.1016/j.neuropharm.2003.11.013  1
2004 Rasmussen K, McCreary AC, Shanks EA. Attenuation of the effects of fluoxetine on serotonergic neuronal activity by pindolol in rats. Neuroscience Letters. 355: 1-4. PMID 14729220 DOI: 10.1016/j.neulet.2003.10.039  1
2003 Gronier BS, Rasmussen K. Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex. Neuroscience Letters. 349: 196-200. PMID 12951202 DOI: 10.1016/S0304-3940(03)00851-6  1
2003 Boothman LJ, Allers KA, Rasmussen K, Sharp T. Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. British Journal of Pharmacology. 139: 998-1004. PMID 12839874 DOI: 10.1038/sj.bjp.0705328  1
2003 Rasmussen K, Vandergriff J. The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal. Neuropharmacology. 44: 88-92. PMID 12559125 DOI: 10.1016/S0028-3908(02)00296-4  1
2001 Dawe GS, Huff KD, Vandergriff JL, Sharp T, O'Neill MJ, Rasmussen K. Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. Biological Psychiatry. 50: 510-20. PMID 11600104 DOI: 10.1016/S0006-3223(01)01171-4  1
2000 Czachura JF, Rasmussen K. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 266-275. PMID 10997729 DOI: 10.1007/s002100000290  1
2000 Rasmussen K, Calligaro DO, Czachura JF, Dreshfield-Ahmad LJ, Evans DC, Hemrick-Luecke SK, Kallman MJ, Kendrick WT, Leander JD, Nelson DL, Overshiner CD, Wainscott DB, Wolff MC, Wong DT, Branchek TA, et al. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine. The Journal of Pharmacology and Experimental Therapeutics. 294: 688-700. PMID 10900249  1
2000 Vandergriff J, Kallman MJ, Rasmussen K. Moxonidine, a selective imidazoline-1 receptor agonist, suppresses the effects of ethanol withdrawal on the acoustic startle response in rats Biological Psychiatry. 47: 874-879. PMID 10807960 DOI: 10.1016/S0006-3223(00)00229-8  1
2000 Shannon HE, Rasmussen K, Bymaster FP, Hart JC, Peters SC, Swedberg MD, Jeppesen L, Sheardown MJ, Sauerberg P, Fink-Jensen A. Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. Schizophrenia Research. 42: 249-59. PMID 10785583 DOI: 10.1016/S0920-9964(99)00138-3  1
2000 Gronier B, Perry KW, Rasmussen K. Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area Psychopharmacology. 147: 347-355. PMID 10672627  1
1999 Gronier B, Rasmussen K. Pertussis toxin treatment differentially affects cholinergic and dopaminergic receptor stimulation of midbrain dopaminergic neurons Neuropharmacology. 38: 1903-1912. PMID 10608285 DOI: 10.1016/S0028-3908(99)00080-5  1
1999 Vandergriff J, Rasmussen K. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal Neuropharmacology. 38: 217-222. PMID 10218862 DOI: 10.1016/S0028-3908(98)00196-8  1
1999 Bymaster F, Perry KW, Nelson DL, Wong DT, Rasmussen K, Moore NA, Calligaro DO. Olanzapine: a basic science update. The British Journal of Psychiatry. Supplement. 36-40. PMID 10211140  1
1999 Bymaster FP, Shannon HE, Rasmussen K, DeLapp NW, Ward JS, Calligaro DO, Mitch CH, Whitesitt C, Ludvigsen TS, Sheardown M, Swedberg M, Rasmussen T, Olesen PH, Jeppesen L, Sauerberg P, et al. Potential role of muscarinic receptors in schizophrenia. Life Sciences. 64: 527-34. PMID 10069519 DOI: 10.1016/S0024-3205(98)00597-9  1
1999 Carlezon WA, Rasmussen K, Nestler EJ. AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine. Synapse (New York, N.Y.). 31: 256-62. PMID 10051106 DOI: 10.1002/(SICI)1098-2396(19990315)31:4<256::AID-SYN3>3.0.CO;2-E  1
1998 Bymaster FP, Shannon HE, Rasmussen K, Delapp NW, Mitch CH, Ward JS, Calligaro DO, Ludvigsen TS, Sheardown MJ, Olesen PH, Swedberg MD, Sauerberg P, Fink-Jensen A. Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane . European Journal of Pharmacology. 356: 109-19. PMID 9774240 DOI: 10.1016/S0014-2999(98)00487-7  1
1998 Gronier B, Rasmussen K. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: An in vivo electrophysiological study in the rat British Journal of Pharmacology. 124: 455-464. PMID 9647468 DOI: 10.1038/sj.bjp.0701850  1
1997 Rasmussen K, Czachura JF. Nicotine withdrawal leads to increased sensitivity of serotonergic neurons to the 5-HT(1A), agonist 8-OH-DPAT Psychopharmacology. 133: 343-346. PMID 9372532 DOI: 10.1007/s002130050411  1
1997 Rasmussen K, Kallman MJ, Helton DR. Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response Synapse. 27: 145-152. PMID 9266775 DOI: 10.1002/(SICI)1098-2396(199710)27:2<145::AID-SYN5>3.0.CO;2-E  1
1997 Bymaster FP, Rasmussen K, Calligaro DO, Nelson DL, DeLapp NW, Wong DT, Moore NA. In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. The Journal of Clinical Psychiatry. 58: 28-36. PMID 9265914  1
1997 Rasmussen K, Gates MR, Burger JE, Czachura JF. The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition. Neuroscience Letters. 222: 61-4. PMID 9121724 DOI: 10.1016/S0304-3940(97)13346-8  1
1997 Bodick NC, Offen WW, Levey AI, Cutler NR, Gauthier SG, Satlin A, Shannon HE, Tollefson GD, Rasmussen K, Bymaster FP, Hurley DJ, Potter WZ, Paul SM. Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Archives of Neurology. 54: 465-73. PMID 9109749  1
1996 Stockton ME, Rasmussen K. Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells Psychopharmacology. 124: 50-56. PMID 8935800 DOI: 10.1007/BF02245605  1
1996 Rasmussen K, Kendrick WT, Kogan JH, Aghajanian GK. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 15: 497-505. PMID 8914123 DOI: 10.1016/S0893-133X(96)00094-2  1
1996 Helton DR, Berger JE, Czachura JF, Rasmussen K, Kallman MJ. Central nervous system characterization of the new cholecystokininB antagonist LY288513 Pharmacology Biochemistry and Behavior. 53: 493-502. PMID 8866946 DOI: 10.1016/0091-3057(95)02122-1  1
1996 Stockton ME, Rasmussen K. Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons Neuropsychopharmacology. 14: 97-104. PMID 8822532 DOI: 10.1016/0893-133X(94)00130-R  1
1996 Rasmussen K, Czachura JF, Kallman MJ, Helton DR. The CCK-B antagonist LY288513 blocks the affects of nicotine withdrawal on auditory startle Neuroreport. 7: 1050-1052. PMID 8804049  1
1996 Krystal JH, Compere S, Nestler EJ, Rasmussen K. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats. Physiology & Behavior. 59: 863-6. PMID 8778878 DOI: 10.1016/0031-9384(95)02206-6  1
1995 Rasmussen K. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal Neuropsychopharmacology. 13: 295-300. PMID 8747753 DOI: 10.1016/0893-133X(95)00082-O  1
1995 Rasmussen K, Czachura JF. Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons Neuroreport. 7: 329-332. PMID 8742482  1
1995 Rasmussen K, Brodsky M, Inturrisi CE. NMDA antagonists and clonidine block c-fos expression during morphine withdrawal Synapse. 20: 68-74. PMID 7624831  1
1995 Rasmussen K. Section review - Central & peripheral nervous systems: Therapeutic potential of cholecystokinin-b antagonists Expert Opinion On Investigational Drugs. 4: 313-322. DOI: 10.1517/13543784.4.4.313  1
1995 Rasmussen K, Rocco VP. Chapter 1. Recent Progress in Serotonin (5-HT)1A Receptor Modulators Annual Reports in Medicinal Chemistry. 30: 1-9. DOI: 10.1016/S0065-7743(08)60914-8  1
1994 Rasmussen K, Helton DR, Berger JE, Scearce E. The CCK-B antagonist LY288513 blocks diazepam-withdrawal-induced increases in auditory startle response Annals of the New York Academy of Sciences. 713: 374-376. PMID 8185192 DOI: 10.1111/j.1749-6632.1994.tb44097.x  1
1994 Rasmussen K. CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons Annals of the New York Academy of Sciences. 713: 300-311. PMID 8185172 DOI: 10.1111/j.1749-6632.1994.tb44078.x  1
1994 Rasmussen K, Yu MJ, Czachura JF. Quinazolinone cholecystokinin (CCK)-B antagonists decrease midbrain dopamine unit activity Synapse. 17: 278-282. PMID 7992203 DOI: 10.1002/syn.890170409  1
1994 Foreman MM, Fuller RW, Rasmussen K, Nelson DL, Calligaro DO, Zhang L, Barrett JE, Booher RN, Paget CJ, Flaugh ME. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity. The Journal of Pharmacology and Experimental Therapeutics. 270: 1270-81. PMID 7523657  1
1993 Rasmussen K, Czachura JF, Stockton ME, Howbert JJ. Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons Journal of Pharmacology and Experimental Therapeutics. 264: 480-488. PMID 8423546  1
1993 Rasmussen K, Howbert JJ, Stockton ME. Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: Mediation through feedback pathways from forebrain sites Synapse. 15: 95-103. PMID 8259526 DOI: 10.1002/syn.890150202  1
1993 Rasmussen K, Berger JE, Helton DR, Scearce E. The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle Neuroreport. 5: 154-156. PMID 8111002  1
1993 Helton DR, Modlin DL, Tizzano JP, Rasmussen K. Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity Psychopharmacology. 113: 205-210. PMID 7855182 DOI: 10.1007/BF02245698  1
1992 Melia KR, Rasmussen K, Terwilliger RZ, Haycock JW, Nestler EJ, Duman RS. Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments. Journal of Neurochemistry. 58: 494-502. PMID 1345939  1
1991 Rasmussen K. Afferent effects on locus coeruleus in opiate withdrawal Progress in Brain Research. 88: 207-216. PMID 1839935  1
1991 Rasmussen K, Fuller RW, Stockton ME, Perry KW, Swinford RM, Ornstein PL. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. European Journal of Pharmacology. 197: 9-16. PMID 1832640 DOI: 10.1016/0014-2999(91)90358-W  1
1991 Rasmussen K, Stockton ME, Czachura JF. The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons European Journal of Pharmacology. 205: 113-116. PMID 1811993 DOI: 10.1016/0014-2999(91)90781-K  1
1991 Rasmussen K, Krystal JH, Aghajanian GK. Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration. Psychopharmacology. 105: 508-12. PMID 1771218 DOI: 10.1007/BF02244371  1
1991 Rasmussen K, Stockton ME, Czachura JF, Jeffry Howbert J. Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity European Journal of Pharmacology. 209: 135-138. PMID 1687681 DOI: 10.1016/0014-2999(91)90025-L  1
1990 Rasmussen K, Aghajanian GK. Serotonin excitation of facial motoneurons: receptor subtype characterization. Synapse (New York, N.Y.). 5: 324-32. PMID 2360199 DOI: 10.1002/syn.890050409  1
1990 Aghajanian GK, Sprouse JS, Sheldon P, Rasmussen K. Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms. Annals of the New York Academy of Sciences. 600: 93-103; discussion 1. PMID 2123618  1
1990 Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 2308-17. PMID 2115910  1
1989 Rasmussen K, Aghajanian GK. Failure to block responses of locus coeruleus neurons to somatosensory stimuli by destruction of two major afferent nuclei. Synapse (New York, N.Y.). 4: 162-4. PMID 2781467 DOI: 10.1002/syn.890040210  1
1989 Aghajanian GK, Rasmussen K. Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse (New York, N.Y.). 3: 331-8. PMID 2740992 DOI: 10.1002/syn.890030406  1
1989 Rasmussen K, Aghajanian GK. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis. Brain Research. 505: 346-50. PMID 2598056 DOI: 10.1016/0006-8993(89)91466-2  1
1988 Rasmussen K, Aghajanian GK. Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 1: 101-7. PMID 2908015  1
1987 Wilkinson LO, Abercrombie ED, Rasmussen K, Jacobs BL. Effect of buspirone on single unit activity in locus coeruleus and dorsal raphe nucleus in behaving cats. European Journal of Pharmacology. 136: 123-7. PMID 3595712 DOI: 10.1016/0014-2999(87)90789-8  1
1986 Rasmussen K, Glennon RA, Aghajanian GK. Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity. European Journal of Pharmacology. 132: 79-82. PMID 3816969 DOI: 10.1016/0014-2999(86)90014-2  1
1986 Rasmussen K, Jacobs BL. Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies. Brain Research. 371: 335-44. PMID 3697762 DOI: 10.1016/0006-8993(86)90371-9  1
1986 Rasmussen K, Morilak DA, Jacobs BL. Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Research. 371: 324-34. PMID 3697761 DOI: 10.1016/0006-8993(86)90370-7  1
1986 Rasmussen K, Strecker RE, Jacobs BL. Single unit response of noradrenergic, serotonergic and dopaminergic neurons in freely moving cats to simple sensory stimuli. Brain Research. 369: 336-40. PMID 3697750 DOI: 10.1016/0006-8993(86)90546-9  1
1986 Rasmussen K, Aghajanian GK. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists. Brain Research. 385: 395-400. PMID 3096493 DOI: 10.1016/0006-8993(86)91090-5  1
1985 Rasmussen K, Jacobs BL. Locus coeruleus unit activity in freely moving cats is increased following systemic morphine administration. Brain Research. 344: 240-8. PMID 4041875 DOI: 10.1016/0006-8993(85)90801-7  1
1984 Heym J, Rasmussen K, Jacobs BL. Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats. European Journal of Pharmacology. 101: 57-68. PMID 6745319 DOI: 10.1016/0014-2999(84)90030-X  1
1984 Rasmussen K, Heym J, Jacobs BL. Activity of serotonin-containing neurons in nucleus centralis superior of freely moving cats. Experimental Neurology. 83: 302-17. PMID 6692870 DOI: 10.1016/S0014-4886(84)90100-6  1
1984 Johnston RE, Rasmussen K. Individual recognition of female hamsters by males: role of chemical cues and of the olfactory and vomeronasal systems. Physiology & Behavior. 33: 95-104. PMID 6505058 DOI: 10.1016/0031-9384(84)90019-2  1
1983 Jacobs BL, Heym J, Rasmussen K. Raphe neurons: firing rate correlates with size of drug response. European Journal of Pharmacology. 90: 275-8. PMID 6873185 DOI: 10.1016/0014-2999(83)90249-2  1
1982 Jacobs BL, Heym J, Rasmussen K. Action of hallucinogenic drugs at postsynaptic serotonergic receptors Psychopharmacology Bulletin. 18: 168-172.  1
Show low-probability matches.